Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Aug;31(8):1204–1209. doi: 10.1128/aac.31.8.1204

Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes.

R J Boon, A S Beale
PMCID: PMC174904  PMID: 3307617

Abstract

The response of Streptococcus pyogenes to amoxicillin or amoxicillin-clavulanic acid (Augmentin; Beecham Group) therapy of a mixed streptococcal-staphylococcal infection was studied in a surgical wound in mice. A superficial wound was produced on the backs of anesthetized mice, and a suture infected with S. pyogenes, Staphylococcus aureus, or a mixed inoculum of both organisms was inserted. Oral therapy was started 4 h after infection and continued for 3 days. Both amoxicillin and amoxicillin-clavulanic acid were effective in eliminating the streptococci from the pure wound infection. In contrast, amoxicillin failed to eliminate the streptococci from a mixed infection in which a beta-lactamase-producing strain of S. aureus was also present, wound counts reaching 10(7) streptococci per wound by 80 h, whereas amoxicillin-clavulanic acid reduced the count to less than 33 streptococci per wound by 24 h. Numbers of S. aureus were also reduced by amoxicillin-clavulanic acid therapy, controlling the infection, whereas amoxicillin was ineffective. Also of significance was the fact that successful therapy was achieved with blood and tissue concentrations of amoxicillin and clavulanic acid of the same order as those measured in humans. These results show that amoxicillin therapy failed to eliminate S. pyogenes from a wound infection in the presence of a beta-lactamase-producing strain of S. aureus and suggest the potential of amoxicillin-clavulanic acid in the treatment of mixed bacterial skin infections involving beta-lactamase-producing organisms.

Full text

PDF
1204

Images in this article

1207Image
on p.1207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam D., de Visser I., Koeppe P. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob Agents Chemother. 1982 Sep;22(3):353–357. doi: 10.1128/aac.22.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes P., Waterworth P. M. New cause of penicillin treatment failure. Br Med J. 1977 Apr 16;1(6067):991–993. doi: 10.1136/bmj.1.6067.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boon R. J., Beale A. S., Comber K. R., Pierce C. V., Sutherland R. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections. Antimicrob Agents Chemother. 1982 Sep;22(3):369–375. doi: 10.1128/aac.22.3.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brook I., Pazzaglia G., Coolbaugh J. C., Walker R. I. In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species. J Antimicrob Chemother. 1983 Dec;12(6):599–606. doi: 10.1093/jac/12.6.599. [DOI] [PubMed] [Google Scholar]
  5. Bryant R. E., Rashad A. L., Mazza J. A., Hammond D. beta-Lactamase activity in human pus. J Infect Dis. 1980 Oct;142(4):594–601. doi: 10.1093/infdis/142.4.594. [DOI] [PubMed] [Google Scholar]
  6. Drelichman V., Cushing R. D., Bawdon R. E., Lerner A. M. Possible pseudoresistance of Streptococcus pneumoniae to penicillin G in a patient with a mixed pneumococcus-Staphylococcus aureus pneumonia. Am J Med Sci. 1984 May-Jun;287(3):39–43. doi: 10.1097/00000441-198405000-00014. [DOI] [PubMed] [Google Scholar]
  7. ELEK S. D., CONEN P. E. The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol. 1957 Dec;38(6):573–586. [PMC free article] [PubMed] [Google Scholar]
  8. ELEK S. D. Experimental staphylococcal infections in the skin of man. Ann N Y Acad Sci. 1956 Aug 31;65(3):85–90. doi: 10.1111/j.1749-6632.1956.tb36626.x. [DOI] [PubMed] [Google Scholar]
  9. Feingold D. S., Taplin D. Infections and infestations of the skin. J Am Acad Dermatol. 1984 Nov;11(5 Pt 2):971–974. doi: 10.1016/s0190-9622(84)80022-5. [DOI] [PubMed] [Google Scholar]
  10. Hackman A. S., Wilkins T. D. Influence of pencillinase production by strains of Bacteroides melaninogenicus and Bacteriodes oralis on pencillin therapy of an experimental mixed anaerobic infection in mice. Arch Oral Biol. 1976;21(6):385–389. doi: 10.1016/s0003-9969(76)80007-6. [DOI] [PubMed] [Google Scholar]
  11. Hunter P. A., Coleman K., Fisher J., Taylor D. In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin. J Antimicrob Chemother. 1980 Jul;6(4):455–470. doi: 10.1093/jac/6.4.455. [DOI] [PubMed] [Google Scholar]
  12. Maddocks J. L., May J. R. "Indirect pathogenicity" of penicillinase-producing enterobacteria in chronic bronchial infections. Lancet. 1969 Apr 19;1(7599):793–795. doi: 10.1016/s0140-6736(69)92063-7. [DOI] [PubMed] [Google Scholar]
  13. Masuda G., Tomioka S. Possible beta-lactamase activities detectable in infective clinical specimens. J Antibiot (Tokyo) 1977 Dec;30(12):1093–1097. doi: 10.7164/antibiotics.30.1093. [DOI] [PubMed] [Google Scholar]
  14. McRipley R. J., Whitney R. R. Characterization and quantitation of experimental surgical-wound infections used to evaluate topical antibacterial agents. Antimicrob Agents Chemother. 1976 Jul;10(1):38–44. doi: 10.1128/aac.10.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Neu H. C., Fu K. P. Clavulanic acid, a novel inhibitor of beta-lactamases. Antimicrob Agents Chemother. 1978 Nov;14(5):650–655. doi: 10.1128/aac.14.5.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Noble W. C. The production of subcutaneous staphylococcal skin lesions in mice. Br J Exp Pathol. 1965 Jun;46(3):254–262. [PMC free article] [PubMed] [Google Scholar]
  17. O'Keefe J. P., Tally F. P., Barza M., Gorbach S. L. Inactivation of penicillin G during experimental infection with Bacteroides fragilis. J Infect Dis. 1978 Apr;137(4):437–442. doi: 10.1093/infdis/137.4.437. [DOI] [PubMed] [Google Scholar]
  18. Parish L. C., Aten E. M. Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor. Cutis. 1984 Dec;34(6):567–570. [PubMed] [Google Scholar]
  19. Reading C., Cole M. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977 May;11(5):852–857. doi: 10.1128/aac.11.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. SIMON H. J., SAKAI W. Staphylococcal antagonism to penicillin-G therapy of hemolytic streptococcal pharyngeal infection. Effect of oxacillin. Pediatrics. 1963 Mar;31:463–469. [PubMed] [Google Scholar]
  21. Schachner L., Taplin D., Scott G. B., Morrison M. A therapeutic update of superficial skin infections. Pediatr Clin North Am. 1983 Apr;30(2):397–404. doi: 10.1016/s0031-3955(16)34366-8. [DOI] [PubMed] [Google Scholar]
  22. Sheagren J. N. Treatment of skin and skin structure infections in the patient at risk. Am J Med. 1984 May 15;76(5A):180–186. doi: 10.1016/0002-9343(84)90262-6. [DOI] [PubMed] [Google Scholar]
  23. Shulman G., Petro J. A., Hallgren E. H. Quantitative bacteriology in wound care. Am Surg. 1979 Jun;45(6):374–377. [PubMed] [Google Scholar]
  24. Wise R., Bennett S. A., Dent J. The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid. J Antimicrob Chemother. 1984 Jun;13(6):603–610. doi: 10.1093/jac/13.6.603. [DOI] [PubMed] [Google Scholar]
  25. de Louvois J., Hurley R. Inactivation of penicillin by purulent exudates. Br Med J. 1977 Apr 16;1(6067):998–1000. doi: 10.1136/bmj.1.6067.998. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES